Q1 2023 Onconova Therapeutics Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics First Quarter 2023 Financial Results and Business Update Conference Call. (Operator Instructions) As a reminder, this call is being recorded today, May 15, 2023.
At this time, I would like to turn the call over to Bruce Mackle of LifeSci Advisors.
Thank you, operator, and welcome, everyone, to Onconova's First Quarter 2023 Financial Results and Business Update Conference Call. Earlier this afternoon, Onconova issued a press release reporting its financial results and business progress. If you have not yet seen this press release, it is available in the Investors & Media section of the company's website at onconova.com.
Following my introduction, we will hear from Onconova's President and CEO; Dr. Steve Fruchtman; Interim Chief Medical Officer, Dr. Michael Saunders; and Chief Operating Officer and Chief Financial Officer, Mark Guerin. Onconova's VP of Regulatory Affairs and Quality Assurance, Fred Frullo, will also be available during the Q&A
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |